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Abstract Pre-operative tracheostomy (POT) to secure a
critical airway up to several weeks before definitive lar-
yngectomy in patients with laryngeal cancer has been
proposed as a risk factor for poor oncologic outcome. Few
modern papers, however, examine this question. The aim
of this study is therefore to determine whether POT affects
oncologic outcome with an emphasis on stomal/peristomal
recurrence. This is a retrospective case note review of 60
consecutive patients undergoing curative primary total
laryngectomy (TL) for advanced laryngeal squamous cell
carcinoma (SCC). Demographic, staging, treatment and
outcome data were collected. 27/60 (45 %) patients had
POT and 33/60 did not. No patient underwent laser deb-
ulking. Median age was 62 years (39–90 years) and med-
ian follow-up of survivors was 31 months. 5-year overall
survival (OS), disease-specific survival (DSS) and local
recurrence-free survival (LRFS) of patients undergoing
POT versus no POT was 28 versus 39 % (p = 0.947), 55
versus 46 % (p = 0.201) and 96 versus 88 % (p = 0.324)
respectively. No statistically significant difference in OS,
DSS and LRFS was found between patients undergoing
POT and those not. Despite the relatively small case series,
this evidence should reassure surgeons without the ability
to perform trans-oral debulking that they should not hesi-
tate to perform tracheostomy on a patient with airway
obstruction due to laryngeal cancer. Appropriate definitive
treatment meant that POT was not a risk factor for poor
oncological outcome in our series.
Keywords Laryngectomy  Tracheostomy  Squamous
cell carcinoma  Local recurrence  Airway
Introduction
Even in the present day, the initial presentation of a patient
with advanced laryngeal cancer can be imminent airway
obstruction. Three options exist to relieve this problem:
trans-oral debulking (TOL) often with a laser, tracheos-
tomy and emergency laryngectomy. The latter technique
has largely been abandoned [1] and there has been a move
away from pre-operative tracheostomy (POT) towards
TOL in recent years. This move has been driven by studies
which showed that POT was associated with a higher risk
of stomal/peristomal recurrence [2–5], and that TOL could
reliably secure the airway [6].
However, on occasion, POT is the easiest way of
securing a critical airway. Indeed, TOL can be limited in its
application as it requires specialist equipment and experi-
ence, in both surgical and anaesthetic fields. TOL also has
the potential disadvantage of post-operative oedema [7]
and rapid tumour re-growth necessitating repeat debulking.
Many studies investigating the oncological risk of POT
are now quite old. Furthermore, the treatment paradigms
and modalities for laryngeal cancer have changed signifi-
cantly in the last 20 years and it is not clear whether the
previous studies on POT are still applicable.
This study was previously presented at the British Association of
Head and Neck Oncology meeting, April 28th 2011. Royal Society of
Medicine, Laryngology section meeting, February 4th 2011.
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Our unit regularly receives patients who have presented
with airway compromise to surrounding smaller hospitals
where they have undergone emergency tracheostomy
before being transferred to us for definitive management.
Indeed our unit still prefers POT to TOL and the aim of this
study was therefore to analyse the impact of POT on
oncological outcome in a contemporary patient cohort
undergoing primary TL.
Materials and methods
After local ethics and audit committee approval, a retro-
spective case note review was performed of 60 consecutive
patients who underwent primary TL for locally advanced
laryngeal squamous cell carcinoma (SCC) performed with
curative intent between 2003 and 2010. Patients who
underwent primary chemoradiotherapy, partial laryngec-
tomy or those treated palliatively from the outset were
therefore excluded.
Patients’ demographic, staging, pre-operative imaging,
treatment and outcome data were collected using case notes,
surgeons’ logbooks and electronic patient records (EPR).
Patient factors analysed included age at procedure and
gender which were retrieved from the hospital electronic
database. Primary site, cTNM classification, type of proce-
dure, extent of neck dissection (ND) and pre-operative tra-
cheostomy (POT) were retrieved from operative records and
radiological imaging reports. Histological features such as
degree of differentiation, the presence of extra-capsular
spread, sarcolemmal/perineural/perivascular invasion, the
presence of a cohesive front, thyroid gland involvement and
adequacy of the pathological margin of excision were col-
lected from surgical histopathological results.
All patients underwent pre-operative computerized
tomography (CT) scanning of the neck and thorax, mag-
netic resonance (MR) scanning when indicated and had
their treatment planned in our multidisciplinary head and
neck tumour (MDT) board meeting. All patients were
staged M0 and treated with curative intent. Both version 6
and 7 of the AJCC staging manual [8, 9] were used as the
study period straddled the change in 2009.
At the time of POT, the approach outlined in Table 1
was systematically adopted whenever possible.
All patients underwent primary TL in our unit, including
comprehensive central compartment (level VI) neck dis-
section [10] with lateral neck dissections as agreed by the
MDT board meeting. All patients with POT had the tra-
cheal window excised and sent for histological analysis. At
the time of definitive surgery, frozen sections were used to
confirm satisfactory margins with critical analysis of the
lower tracheal margins following excision of the POT tract
as part of an en bloc surgical specimen. All patients had
critical evaluation and management of the thyroid gland.
This included ipsilateral thyroid lobectomy with isthmus-
ectomy on the side of the tumour or total thyroidectomy
when pre-operative staging suggested thyroid involvement,
an approach validated by earlier research [11]. The treat-
ment plan included post-operative radiotherapy (PORT) for
all patients and after 2008, patients with positive margins
or extra-capsular spread were planned for post-operative
chemoradiotherapy (CRT). For a variety of reasons, not all
patients were able to complete adjuvant treatment.
Local recurrence (LR) was defined as recurrent squamous
cell carcinoma (SCC), diagnosed within 5 years of initial
treatment involving the immediate stomal and peri-stomal
region. Regional recurrence (RR) was defined as recurrent
SCC involving the cervical nodes level 1–5. Distant recur-
rence was diagnosed either clinically or on imaging studies
including ultrasound guided fine needle aspiration, CT or
positron emission tomography (PET) scanning. All recur-
rences were biopsy proven except in those patients in which
it was felt that either co-morbid status or disease progression
meant that invasive biopsies were not indicated. All cases
were discussed within the MDT, and those patients not fit for
biopsy were considered as recurrence by consensus based on
clinical or imaging examination.
Evidence of patients’ death was taken from hospital
records and death certificates where available. All patients
with active disease at last follow-up who died of unknown
causes were considered as having died of disease.
Statistical analysis of overall survival (OS), disease-
specific survival (DSS) and local recurrence-free survival
Table 1 Modern approach to total laryngectomy
At the time of POT
Excision and histological analysis of the excised tracheal
window and the thyroid isthmus and Delphian node at POT
Placement of the tracheostomy between the 2nd and 4th tracheal
rings
Inspection of the lower margin of the trachea before tube
placement
At the time of definitive TL
Minimal interval time between POT and TL
Comprehensive wide field TL with lateral compartment neck
dissections
Excision of the tracheostomy tract at definitive surgery
Critical appraisal of thyroid involvement, including evaluation of
the invasion of the thyroid gland, ipsilateral hemithyroidectomy
with isthmusectomy on the side of the tumour or total
thyroidectomy when indicated
Frozen section margin control especially of the lower tracheal
margin
Central compartment (level VI) neck dissection
Post-operative management
Post-operative radiotherapy or chemo-radiation therapy
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(LRFS) were calculated using the Kaplan–Meier method.
The log-rank test was used for univariate, and cox-regres-
sion model for multivariate analysis (SPSS, Chicago, Illi-
nois, v19). Comparison of subgroups was performed using
the Fishers exact test.
Results
Sixty patients with median age of 62 years (39–90 years)
were analysed. Forty-nine were male (82 %), 11 were
female (18 %). The median follow-up was 16 months
(range 1–91 months), with a median follow-up for survi-
vors of 31 months (range 4–91 months). 27/60 (45 %)
patients had POT. No patients had TOL. The majority of
patients undergoing POT had awake fibreoptic intubation
in line with anaesthetic guidelines [12].
Procedure, location of primary, pT and pN stage and
histology are shown in Table 2. All patients underwent TL
and 29 also had partial pharyngectomy (48 %). Forty-eight
had laryngeal (80 %) and 12 hypopharyngeal primaries
(20 %). All patients had comprehensive central neck
dissection. Fifty-five patients underwent bilateral (92 %)
lateral neck dissection and five patients had unilateral
(8 %) neck dissection.
Two patients died within 30 days of surgery (peri-
operative deaths) due to carotid blow out. Both had
extensive disease peeled off the carotid during surgery and
had involved margins. A further 34 patients died during
follow-up, 24 of these from their disease (5 LR, 2 RR and
17 DR).
For the whole cohort of patients, 5-year overall survival
(OS), disease-specific survival (DSS) and local recurrence-
free survival (LRFS) were 36, 51, 92 % respectively
(Fig. 1).
As expected, the presence of nodal metastasis predicted
worse disease-specific survival (pN0 5y DSS 74 vs
pN ? 32 %, p = 0.008). This was, however, most likely
because N = stage is a predictor of distant metastasis.
Indeed loco-regional control rates were excellent. No sig-
nificant association was found between tumour site and risk
of recurrence, though this was probably due to small
numbers.
POT versus no POT
1/27 (3.7 %) patients with POT had local recurrence during
follow-up compared to 4/33 (12 %) patients without POT.
5-year overall survival (OS), disease-specific survival
(DSS) and local recurrence-free survival (LRFS) of
patients undergoing POT versus no POT was 28 versus
39 % (p = 0.947), 55 versus 46 % (p = 0.201) and 96
versus 88 % (p = 0.324), respectively.
POT was therefore not statistically associated with poorer
outcome in terms of OS, DSS or LRFS (Figs. 2, 3, 4).
Subgroup analysis/bias
Due to the non-randomised nature of our study, we ana-
lysed whether the POT and non-POT group were similar in
terms of ages, co-morbidities and TNM classification. The
groups were similar though the POT group had a higher
rate of pT3 than pT4 disease (Table 3). This counter-
intuitive result did not show any significant correlation
Table 2 Description of patients and disease
Factor Number of patients (%)
Ablative
Total laryngectomy 31 (52 %)
Plus Pharyngectomy 29 (48 %)
Location
Subglottic 1 (2 %)
Glottic 4 (7 %)
Supraglottic 22 (37 %)
Transglottic 20 (33 %)
Hypopharynx 12 (20 %)
Incomplete records 1 (2 %)
pT stage
T3 15 (25 %)
T4 44 (73 %)
Incomplete records 1 (2 %)
pN stage
N0 18 (30 %)
N1 10 (17 %)
N2a 1 (2 %)
N2b 13 (22 %)
N2c 14 (23 %)
N3 1 (2 %)
Incomplete records 3 (5 %)
Histological differentiation
Well differentiated 3 (5 %)
Moderately differentiated 25 (42 %)
Poorly differentiated 29 (48 %)
Incomplete records 3 (5 %)
Extranodal spread in N? (n = 39)
Yes 27 (69 %)
No 11 (28 %)
Incomplete records 1 (3 %)
Tracheostomy
POT 27 (45 %)
No POT 33 (55 %)
Eur Arch Otorhinolaryngol (2013) 270:1729–1735 1731
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with likelihood of POT (data not shown). Further subgroup
analysis was performed by pT classification. Again POT
was not predictive of outcome in either subgroup when
analysed separately. POT remained a non-significant
prognostic factor in outcome analysis of the T-classifica-
tion subgroups i.e. pT3 POT versus pT3 non-POT and pT4
POT versus pT4 non-POT.
We further reanalysed our data assuming the incomplete
records were either ‘‘positive’’ or ‘‘negative’’. In no
instance did this change our result that there was no
statistically significant association between POT and
outcome.
Overall, we feel the patients who underwent POT were
globally more compromised by their disease and co-mor-
bidities and therefore would have expected these patients to
perform worse than patients who did not undergo POT. The
fact that we did not find a significant difference is therefore
all the more striking.
Discussion
Laryngeal cancer is the only cancer for which survival rates
have worsened over the last 20 years [13, 14]. The reasons
for this have been contested [14–16] and potentially
include worsening co-morbidities and the increased use of
chemoradiation. Surgically speaking we can only focus on
local and regional control and this paper addresses an
important question regarding the risk of stomal/local
recurrence.
Stomal recurrence following primary total laryngectomy
(TL) for squamous cell carcinoma occurs in 2–15 % [17,
18] and has been defined as ‘‘a diffuse infiltration of neo-
plastic tissue at the junction of the trachea and skin’’ [17].
It is difficult to distinguish from spread from local level VI
lymph nodes and the thyroid gland. Indeed in this paper we
have not attempted to distinguish between these particular
types and classify all stomal/peri-stomal recurrences as LR.
Patients presenting with local recurrence have a dismal
outcome with approximately 50 % presenting in the first
year after completion of treatment [3, 4] and 80 % dying in
the first 2 years after completion of treatment [19].
Pre-operative tracheostomy (POT) performed up to
several weeks before definitive laryngectomy is one of
several risk factors identified originally in the 1960s as
being associated with increased risk of LR (Table 4). Since
that time several papers have shown a poor outcome with
POT [3, 5, 20] and others have found no relation [21–26].
Intuitively it seems plausible that POT might disrupt the
primary tumour, seed the tract and therefore lead to worse
local control (Fig. 5). Some authors have argued to place
the tracheostomy low [27] in order to avoid any subglottic
extension of the tumour, whereas others have argued for a
high tracheostomy [17] which can then be more easily
completely excised at the time of definitive laryngectomy.
Theoretically also any time delay between the POT and the
definitive TL would allow the seeded cancer to more
effectively establish itself in the fresh tracheostomy wound
bed.
Fig. 1 Kaplan–Meier survival for the whole cohort
Fig. 2 Overall survival stratified by POT
1732 Eur Arch Otorhinolaryngol (2013) 270:1729–1735
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Evidence for the intuitive risk of POT comes from
diverse sources. For example, there are case reports
describing stomal recurrence in the setting of non-lar-
yngeal/hypopharyngeal primaries. This raises the suspicion
that cancer cells are able to inoculate the fresh tracheos-
tomy wound [28, 29]. Stell [4] reported one case of a
patient who had a maxillectomy performed with a covering
tracheostomy who developed recurrence around the
tracheostomy site 2 years later. McGurk [30] also reports
three cases of patients who had a prophylactic tracheos-
tomy for intra-oral resections that developed recurrence at
the tracheostomy site. Clayman et al. [31] reported two
cases of stomal recurrence with oropharyngeal primaries.
There are even case reports of gastric metastasis from oral
squamous cell carcinoma following PEG insertion [32].
Supporting these case reports are laboratory studies which
have investigated vital looking tumour cells recovered
from tracheal swabs or endo-tracheal tubes [33]. Though
these could not be grown on intact mucosa, suspicions
remain about them seeding a fresh tracheostomy wound.
Overall, however, we do not have a particularly good
understanding of how LR occurs [19]. The terminology
used in the literature is not necessarily consistent making
meta-analyses difficult. Some authors use the word
‘‘recurrence’’ when actually describing residual disease
following incomplete excision or when potentially positive
central compartment lymph nodes have not been addressed
as part of the definitive treatment. Other papers use the
term stomal recurrence and it is not clear if this would
include direct spread from level VI or the thyroid.
Others do not differentiate between primary and salvage
laryngectomy.
Furthermore, much of the literature quoted is quite old.
Nowadays, with the increasing use of chemoradiotherapy,
primary laryngectomy is often reserved for patients with
Fig. 3 Disease-specific survival stratified by POT
Fig. 4 Local recurrence-free survival stratified by POT
Table 3 Comparison of POT and non-POT groups
Number of patients
undergoing POT
N = 27
Number of
patients without
POT N = 33
p value
(Fischer’s
exact test)
Gender
Male 23 26 0.53
Female 4 7
Age (years)
\60 10 16 0.80
[60 17 17
pT stage
T3 10 5 0.03
T4 17 27
N0/N?
N0 9 9 1.00
N? 17 22
Stage
Stage
III
4 3 0.17
Stage
IV
23 30
Eur Arch Otorhinolaryngol (2013) 270:1729–1735 1733
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the most advanced local disease meaning that it is not
necessarily possible to compare old data with modern
series. The exact description of TL is also missing from
many papers (for example whether the central compart-
ment or thyroid was removed) again making comparisons
difficult. We therefore felt that a consistent modern surgi-
cal approach in a modern patient cohort was needed to look
at whether POT affects outcome following primary TL.
This is an important question, as even in the twenty-first
century, many patients with advanced laryngeal cancer
present with such severe airway compromise as to require
emergency airway management. Though several protocols
exist as to how to judge how severely compromised an
airway is [12, 34], often objective measures of respiratory
rate, fatigue, pulse oximetry etc. interplay with subjective
measures of stridor and feelings of panic from both the
patient and surgeon.
Securing a safe airway allows for appropriate investi-
gations and staging as well as allowing fully informed
consent before definitive treatment. Although laser surgery
has theoretical oncological advantages, as it prevents dis-
ruption to tissue planes and minimises the chance of
tumour seeding, it intuitively is not quite as safe as a POT
in terms of securing the airway as there remains the
potential risk of post-operative oedema [7], aspiration, and
tumour re-growth. Furthermore, both the surgical and
anaesthetic skills and instruments required to perform such
procedures are often not available out of office hours or in
smaller hospitals where such patients may present. Even if
patients can be temporarily stabilised with inhalational
therapies, some more advanced lesions are just not ame-
nable to TOL. In such patients, POT may be the only safe
option for the airway, irrespective of oncological concerns.
It must be stated, however, that our study is not a
comparison of TOL versus POT, but rather a reassurance to
surgeons who can be faced with a critical airway and no
access to more advanced airway techniques. Our conten-
tion is that with sufficiently aggressive definitive manage-
ment as described in Table 1, carried out within a
reasonably short timeframe from the POT, that any
increased risk associated with POT can be eliminated.
We would also like to highlight the multi-modal nature
of our treatment which uses adjuvant post-operative irra-
diation of the surgical bed and bilateral neck nodes to
reduce the risk of loco-regional recurrence [35]. To further
improve locoregional recurrence rates [36, 37], post-oper-
ative chemoradiation [38] with high dose cisplatin and
60–66 Gy in 30–33 daily fractions has become the standard
of care in our unit since 2008 for patients with positive
margins and/or extracapsular spread [39], the two most
unfavourable parameters.
In conclusion, management of the compromised airway
in advanced laryngeal carcinoma remains a challenge.
Whilst it is important that teams dealing with head and
neck cancers are familiar with the use of TOL and endo-
laryngeal surgical techniques, our results are in keeping
Table 4 Risk factors thought to be associated with poor outcome
following total laryngectomy
Risk factors [4]
Size of tumour
Location of tumour (e.g. subglottic)
Lymph node involvement (e.g. paratracheal)
Incomplete removal of tumour
Inoculation of tumour cells
Pre-operative tracheostomy
Endotracheal intubation
Fig. 5 Involvement of POT
site in cancer
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with more recent studies, which suggest that POT is not
necessarily related to poor oncological outcome. It is a
technique that can be easily taught, requires standard
equipment available in all operating theatres and is suited
to almost all advanced laryngeal lesions. Despite limita-
tions imposed by the cohort size and potential lack of
power, this paper provides evidence that POT is not a risk
factor for poor outcome.
Conflict of interest None.
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